Intravenous Alteplase is Associated with First Pass Effect in Stent-retriever but not ADAPT Thrombectomy

• Published in: Clinical neuroradiology (Munich) Vol. 32; no. 1; pp. 153 - 162
• Main Authors: Shigeta, Keigo, Suzuki, Kentaro, Matsumaru, Yuji, Takeuchi, Masataka, Morimoto, Masafumi, Kanazawa, Ryuzaburo, Takayama, Yohei
• Format: Journal Article
• Language: English
• Published: Heidelberg Springer 01.03.2022; Springer Nature B.V
• Subjects: Catheters; Clinical outcomes; Medical colleges; Medical research; Medicine, Experimental; Patients; Stent (Surgery); Stroke; Stroke (Disease); Tissue plasminogen activator
• ISSN: 1869-1439; 1869-1447
• DOI: 10.1007/s00062-021-01085-3

Purpose To investigate the effect of alteplase, either combined with stent-retriever thrombectomy or a direct aspiration first pass technique (ADAPT), in patients with large-vessel occlusion stroke. Methods This was a retrospective post hoc analysis of data from The Direct Mechanical Thrombectomy in Acute LVO Stroke (SKIP) study. Patients were divided into two groups according to the first-line thrombectomy technique: stent-retriever and ADAPT. Each group was further divided into two subgroups, namely MT and MTâ¯+ alteplase. The procedural outcomes, such as first pass effect (FPE) ratio and number of passes, were evaluated. The clinical outcomes included mRS score at 3 months. Results A total of 180 patients were included (116 in the stent-retriever group and 64 in the ADAPT group). No interaction was detected between the first-line technique and alteplase administration. In the stent-retriever group, after adjusting for factors associated with FPE, the adjusted odds ratio (95% confidence interval) of FPE of the MTâ¯+ alteplase subgroup versus the MT subgroup was 3.57 (1.5-8.48) and in the ADAPT group it was 1.35 (0.37-4.91). With alteplase, the number of passes decreased with adjusted odds ratios of 0.59 (0.37-0.93) in the stent-retriever group but not in the ADAPT group. In both first-line technique groups, clinical outcomes did not differ between subgroups. Conclusion In the SKIP study, alteplase administration was associated with increased FPE when combined with stent-retriever thrombectomy, but not with ADAPT. We found no differences in the clinical outcomes.